Funding for this research was provided by:
Received: 10 May 2021
Accepted: 6 July 2021
First Online: 16 July 2021
: The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. The study used anonymous data and, based on National and International regulations, a waiver was applied to the requirement for patients’ informed consent.
: Not applicable.
: MLM received Grant support, lecture or consultant fees from Lilly, Merck Sharp & Dome, Mylan, Servier, Amryt and SLAPharma. AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, Neopharmed Gentili, and Takeda.